Aptevo Therapeutics (APVO) said Thursday it will implement a one-for-20 reverse stock split, which is expected to become effective on Friday, to meet Nasdaq listing requirements.
Trading on a split-adjusted basis is set to begin Tuesday under the existing APVO ticker, Aptevo said.
The company said the move, approved by shareholders and its board, will reduce the number of outstanding shares from about 13.5 million to roughly 700,000. It will also adjust outstanding stock-based awards and securities, Aptevo said, adding that no fractional shares will be issued, and shareholders will receive cash for any fractions.
Shares of Aptevo were down more than 18% in recent premarket activity.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。